Hearing Loss Trial, Recruiting NCT06499584 Sponsor: CHU de Reims Condition: Hearing Loss
Back to Hearing Loss

Hearing Loss Trial, Recruiting

NCT06499584
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 to 80 years, of any gender
  • People with a normal-looking ear canal and eardrum on examination by a doctor
  • People who are already scheduled for a specific type of brain surgery involving an area near the ear called the cerebellopontine angle (a procedure called microvascular decompression)
  • People enrolled in a social security scheme
  • People who have read the study information and agreed to take part by signing a consent form
  • For the hearing-impaired group: People with mild hearing loss in the inner ear or hearing nerve, measured at a specific range on a hearing test (between 21 and 40 dB HL across several sound frequencies)
  • For the normal-hearing group: People with no inner ear or hearing nerve hearing loss, with hearing test results at or below 20 dB HL across several sound frequencies, in both ears

Who may not be able to join:

  • People whose hearing nerve cannot be reached during surgery due to a tumour that has fully grown into the nerve (advanced-stage tumours, such as stage III or IV neuroma, or advanced meningioma)
  • People whose anatomy, not identified before surgery, makes it impossible to access the hearing nerve during the operation (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 03 26 78 71 25

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
CHU de Reims
Registry
ClinicalTrials.gov
Start date
21 March 2023
Est. completion
1 December 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

To compare the amplitude of coding of complex and ecological sounds; To compare the spectrum of coding of complex and ecological sounds

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov